These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 4608970

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Multicenter clinical, double blind, and randomized study to assess the effectiveness and safety of binifibrate versus gemfibrozil in type IIa, IIb, and IV hyperlipidemia].
    Corominas Vilardell A, de Oya Otero M, Escobar Jiménez F, Anguera Vila A, Ariño Armengol B.
    An Med Interna; 1993 Nov; 10(11):537-41. PubMed ID: 8117868
    [Abstract] [Full Text] [Related]

  • 23. Evaluation of increasing doses of gemfibrozil in hyperlipoproteinaemia.
    Lageder H, Irsigler K.
    Proc R Soc Med; 1976 Nov; 69 Suppl 2(Suppl 2):71-5. PubMed ID: 798199
    [No Abstract] [Full Text] [Related]

  • 24. Clinical research into the hypolipemic and platelet antiaggregant activity of plafibride, Carried out in double-blind conditions and in comparison with clofibrate.
    Palmieri B, Gasparini Casari M, DiBlasio P, Zirilli E.
    Arzneimittelforschung; 1981 Nov; 31(10a):1863-6. PubMed ID: 7032534
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Changes in the lipid profiles of hyperlipemic patients treated with binifibrate].
    Avellaneda A, Rueda A, Cascio C, Gutiérrez JA.
    An Med Interna; 1993 Jun; 10(6):275-9. PubMed ID: 8334204
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial.
    McCrindle BW, Ose L, Marais AD.
    J Pediatr; 2003 Jul; 143(1):74-80. PubMed ID: 12915827
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Experience with the medical treatment of chronic cerebrovascular insufficiency: bamethan and inositol nicotinate versus placebo].
    Cucinotta D, Silvestrini C, Mancini M, Maini C, Passeri M.
    G Clin Med; 1981 May; 62(5):339-50. PubMed ID: 6115790
    [No Abstract] [Full Text] [Related]

  • 35. [Comparative studies of the response of normolipemic and dyslipemic aged subjects to 2 forms of delayed-action nicotinic acid polyesters. Pentaerythrotol tetranicotinate and inositol hexanicotinate. Results of a controlled cross-over trial].
    Ziliotto GR, Lamberti G, Wagner A, Cima L, Genco G.
    Arch Sci Med (Torino); 1977 May; 134(4):359-94. PubMed ID: 345998
    [Abstract] [Full Text] [Related]

  • 36. [Drug therapy of hyperlipidemias].
    Wolfram G.
    Wien Med Wochenschr; 1981 May; 131(13-14):333-8. PubMed ID: 7281700
    [No Abstract] [Full Text] [Related]

  • 37. [Arteriosclerosis--nicotinic acid therapy. 7. Effect of nicotinic acid on lipoproteins].
    Carlson LA.
    Lakartidningen; 1971 Apr 07; 68(15):1763-4. PubMed ID: 5577249
    [No Abstract] [Full Text] [Related]

  • 38. [Acipimox (Olbetam) as a secondary hypolipemic agent in combined hypertriglyceridemia and hyperlipidemia].
    Yeshurun D, Hamood H, Morad N, Naschitz J.
    Harefuah; 2000 Apr 16; 138(8):650-3, 710. PubMed ID: 10883206
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Drug therapy of dyslipidemias].
    Fonda M, Cattin L, Guarnieri G.
    Recenti Prog Med; 2000 Apr 16; 91(7-8):375-8. PubMed ID: 10932924
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.